The European School of Neonatology (ESN)

Improving professional neonatal care in Europe and beyond

About the ESN

The European School of Neonatology (ESN) represents the educational arm of the European Society for Paediatric Research (ESPR).

It is a non-for-profit organisation that offers a clinically-integrated Master of Advanced Studies (MAS) in Neonatology, an academic Master of Science (MSc) in Neonatology in collaboration with the University of Southampton, dedicated Special Courses and Training and the lecture series 'Perspectives on Effective Neonatology'.

Taking into account principles of evidence-based medicine, the programme joins theory and practice to equip medical professionals with the right competencies to practice Neonatology at all levels of care.

Find out more via the dedicated ESN website esn-education.org

We would like to thank our partners for their support of the ESN

	Aguettant is a family-owned pharmaceutical company dedicated to the development, industrial production and distribution of innovative injectable pharmaceutical specialties that meet the demands and the needs of healthcare professionals and patients. Founded in Lyon, France in 1903, Laboratoire Aguettant's growth has been rooted in its engagement with the medical world and its pharmaceutical expertise in injectable medication.
	AstraZeneca is a global, science-led, patient-focused pharmaceutical company. It is focused on creating genuinely innovative medicines and improving access to them. Inspired by its Values and what science can do, AstraZeneca is focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
	Krankenhaus Barmherzige Brüder Regensburg is the largest Catholic hospital in Germany and a teaching hospital of the University of Regensburg. Around 3,300 employees in 30 clinics and institutes as well as in 34 centres take care of about 52,000 inpatients and 115,000 outpatients annually. Since 2021, the Barmherzige Brüder Regensburg Hospital has been given the mandate of a maximum care provider.
	Medela turns science into care while nurturing health for generations, through advancing research, observing natural behavior and listening to its customers. Medela supports millions of moms, babies, patients and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela is dedicated to developing innovations that build better outcomes, providing the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education.